ArticleBioMed research international2015

Modified weekly cisplatin-based chemotherapy is acceptable in postoperative concurrent chemoradiotherapy for locally advanced head and neck cancer.

Hsueh-Ju Lu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.